CCR2 and central nervous system cancer: Our earlier studies established that CCR2+/CX3CR1+ myeloid cells, characterized by M-MDSC markers (CD45, CD11b, Ly6Chi, and lack Ly6G), are present in the bone marrow and infiltrate into multiple murine gliomas (KR158B and 005 GSC).